EU GMP Certification for Biocon

Biocon Biologics India, a subsidiary of Biocon has received the Certificate of GMP compliance from EMA

229
Approved
Picture: Pixabay

EU GMP Certification for Biocon

Biocon Biologics India, a subsidiary of Biocon has received the Certificate of GMP compliance from EMA represented by the competent authority of Germany for its Biologics Drug Substance (DS), facilities at 20th KM, Hosur Road, Bengaluru.

These facilities are used for the manufacture of drug substance of Pegfilgrastim and Recombinant Human Insulin and manufacturing related activities for Insulin Glargine and Insulin Aspart and were inspected by the regulatory agency between January 20 and 23, 2020.

Also read: These 4 Covid-19 vaccines are leading the race

Compliance

“This certification will enable us to continue addressing the growing needs of patients in the EU markets and enhance access to our high-quality biosimilars. We remain committed to global standards of quality and compliance,” informed a company release.

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.